← Leaderboards
Elizabeth Peterson-Roth
L2 Diagnostics, Llc
$2,514,520
Attributed
$2,514,520
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2012–17$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,514,520 · 3
By mechanism
N44$1,996,011 · 1
R43$518,509 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Morbidity - Disease Rate”
- Marco Pahor · Wake Forest University Health Sciences$29,421,775
- A Benedict Cosimi · Massachusetts General Hospital$17,236,164
- Judith S. Currier · University Of California Los Angeles$11,229,603
- Andrea Jenay Ruff · Johns Hopkins University$10,896,035
- Lucile L Adams-Campbell · Howard University$10,384,616
- Michael K Ong · University Of California Los Angeles$9,898,332
Research focus
Morbidity - Disease RateProteinsCd34 GeneLaboratoriesOligonucleotidesPeptide Nucleic AcidsDesignGene-ModifiedGenetic RecombinationIn VivoMortality Vital StatisticsMutationAutologousBackGenesCellsFrequencies (Time Pattern)BloodAdverse OutcomeGene TargetingHematopoietic Stem Cell TransplantationImmuneModificationProtocols Documentation
Grant awards (3)
IGF::OT::IGF SBIR Phase II: Topic 338 - Predictive Biomarkers of Adverse Reactions to Prostrate Cancer Radiotherapy$1,996,011
N44 · FY2017 · CA · contact PI
Targeted Inactivation of the CCR5 HIV Coreceptor with Peptide Nucleic Acids$250,298
R43 · FY2014 · AI · contact PI
Triplex-mediated DNA repair as a novel therapy for Hurler Syndrome patients$268,211
R43 · FY2012 · NS · contact PI